Scholars Central

Conference abstractPublished 25 Jun 2018

Untitled abstract

Authors: Ian James

Edith Cowan University, Australia

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The limitations of laboratory medicine with relevance to biomarker tests and global organ disease Various diagnostic technologies have been used with relevance to genomics, lipidomics, and proteomics to allow more sensitive interpretations with relevance to early cell dysfunction. The diagnostic technologies encompass the genome, transcriptome, proteome, and metabolome (central dogma of biology) and determine the cell genome (nuclear receptors) and transcription factor alterations with relevance to concentrations of plasma lipids and proteins. The projected cost of plasma and cell biomarker analysis is expected to be approximately 52 billion dollars by the year 2020. Major efforts with biomarkers have been identified with plasma protein panels to assess progression and severity of diseases. In spite of laboratory medicine and various analyte measurements for chronic diseases early abnormal nuclear-mitochondria interactions have not been identified with toxic immune reactions involved in mitochondrial apoptosis and the induction of programmed cell death. Figures if any

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • BylineArticles whose byline prints “Ian James”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels